Catalyst Wire Dossier Catalyst Wire Dossier

Diquafosol Sodium 3%

diquafosol sodium · Santen Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diquafosol Sodium 3%, covering 2025-08-14 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness of Dry Eye Treatment With Diquafosol Sodium 3% After Phaco Surgery

See pricing